Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
British Medical Journal|November 2, 1974
Vasculitis with alclofenac therapyR A Billings, H C Burry, F S Emaslie, et al.Journal of the Royal Society of Medicine|April 1, 1981
Dietary allergy and specific IgE in ulcerative colitisD B Jones, G D Kerr, J H Parker, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 23, 2006
Mortality in individuals with Type 2 diabetes and heart disease in a unique New Zealand populationG D Kerr, G D Gamble, R N Doughty, et al.Australian and New Zealand Journal of Medicine|February 1, 1977
Imaging of acute myocardial infarction using technetium 99m labelled phosphate compoundsG D Kerr, A Pitt, C C Wong, et al.BMJ (Clinical Research Ed.)|November 26, 1988
Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmaticsR A Nagel, P Brown, W H Perks, et al.Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
The correlation between acid suppression and peptic ulcer healingR H Hunt, C W Howden, D B Jones, et al.Journal of Animal Science|December 1, 1990
Exogenous human growth hormone-releasing factor and ovine somatotropin improve growth performance and composition of gain in lambsD H Beermann, D E Hogue, V K Fishell, et al.Gut|September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugsD B Jones, C W Howden, D W Burget, et al.Archives of Razi Institute|July 3, 2023
The Impact of Human Mammary Tumor Virus (HMTV) on the Expression of Epidermal Growth Factor Receptor (EGFR) and Death-Domain Associated Protein (DAXX) in Breast Carcinoma TissuesH Ali Naeem, W Nazar Ibraheim, S A Abdullah AlomarAlimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitisJ R B Green, J C Mansfield, J A Gibson, et al.Pageof 4